Novo Nordisk ... its U.S. manufacturing capacity to address the growing demand for its highly sought-after weight-loss-related drugs. The Danish pharmaceutical manufacturer will also boost its ...

Novo Nordisk has gone up another gear in its drive to boost manufacturing ... injectables in North Carolina, US. The new plant will be one of the largest manufacturing investments in Novo Nordisk ...

Drugmaker Novo Nordisk expects Wegovy weight-loss drug sales in the United States to start to recover once a ban on compound ...

Novo Nordisk ... manufacturing facility, but will be spent “across the entire global value chain from manufacturing of [API] to packaging,” said the company. The new plant will boost capacity ...

Compounders quickly cranked into overdrive, manufacturing ... Steve Benz, Novo's legal chief, said in a release. "FDA's determination was based on a thorough review of Novo Nordisk's stable ...

Shares of Novo Nordisk closed around 1% lower on Thursday, while Eli Lilly's stock closed more than 11% lower. It comes as Novo Nordisk works to boost access ... across the US healthcare system ...

SAO PAULO (Reuters) - Novo Nordisk, the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil to boost production, it said on Monday. The ...

April 14 (Reuters) - Danish drugmaker Novo Nordisk NOVOb.CO said on Monday several hundred counterfeit units of its diabetes drug Ozempic were being distributed outside its authorized supply chain ...

It subsequently sold three Catalent manufacturing plants to Novo Nordisk for $11 billion to boost Wegovy production. However, total assets under management dropped slightly to 142 billion euros in ...